健脾丸加味治疗化疗患者食欲不振疗效观察
第1页 |
参见附件(1425KB,2页)。
[摘要] 目的:观察健脾丸加味治疗化疗引起食欲不振的临床疗效。方法:使用健脾丸加味治疗化疗引起食欲不振患者42例,连服1周为1个疗程,并观察疗效,每位患者连续治疗2个周期,同时设立对照组患者40例,不服用任何相关治疗药,作为对照观察。结果:治疗组42例共84个周期,显效61次,占72.6%;有效14次,占16.7%;无效9次,占10.7%。总有效率为89.3%。对照组40例共80周期,显效15次,占18.8%;有效20次,占25.0%;无效45次,占56.2%。总有效率为43.8%。两组比较差异有统计学意义(P=0.005)。结论:健脾丸加味是治疗化疗引起食欲不振的有效方药,安全、无明显毒副反应。
[关键词] 健脾丸;中医治疗;食欲不振;化疗
[中图分类号] R97 [文献标识码] B [文章编号] 1674-4721(2011)12(b)-100-02
Curative effect observation of Jianpi pill on the treatment of chemotherapy in patients with anorexia
LI Shoushan
Traditional Chinese Medicine Hospital of Siyang County in Jiangsu Province, Siyang 223700, China
[Abstract] Objective: To observe clinical curative effect of Jianpi pill on the treatment of chemotherapy-induced anorexia. Methods: Used Jianpi pill on the treatment of 42 cases with chemotherapy-induced anorexia, taken a week for a course of treatment, and the curative effect was observed, each patient were consecutively treated for two cycles, set up 40 cases for control group at the same time, did not take any related medications, as the control observation. Results: 42 cases in the treatment group were treated for a total of 84 cycles, marked effect in 61 times, accounting for 72.6%; effective in 14 times, accounting for 16.7%; invalid in 9 times, accounted for 10.7%. The total effective rate was 89.3%. 40 cases of the control group were treated for a total of 80 cycles, marked effect in 15 times, accounted for 18.8%; effective in 20 times, accounting for 25%; invalid 45 times, accounted for 56.2%. The total effective rate was 43.8%. There was significant difference between the two groups (P=0.005). Conclusion: Jianpi pill on the treatment of chemotherapy-induced anorexia is an effective prescription, it is safety, has no obvious toxic side reaction.
[Key words] Jianpi pill; Traditional Chinese medicine treatment; Anorexia; Chemotherapy
食欲不振是肿瘤患者化疗过程最常出现的不良症状,其发生率高达80%。影响患者身体及精神的恢复,是患者不能按时治疗甚至拒绝治疗的重要原因之一。本科2008年10月~2010年3月用健脾丸加味治疗化疗引起食欲不振患者42例,取得了较满意的疗效。总结如下:
1 资料与方法
1.1 一般资料
治疗组42例患者,男27例,女15例,年龄45~78岁,中位年龄61岁,其中,食管癌11例、胃癌6例、结直肠癌5例、肺癌7例、乳腺癌8例、恶性淋巴瘤3例、头颈部肿瘤2例。对照组40例患者,男26例,女14例,年龄43~80岁,中位年龄60岁,其中,食管癌8例、胃癌7例、结直肠癌4例、肺癌8例、乳腺癌7例、恶性淋巴瘤2例、头颈部肿瘤3例,卵巢癌1例。以上病例Karnofsky评分>60分,预期生存期>3个月,无严重心、肺、肝、肾功能障碍等其他器质性疾病。化疗后食欲不振程度见表1,食欲减退程度判定标准[1]:轻度,进食量较正常减少1/3以下;中度,进食量较正常减少1/3以上,2/3以下;重度,进食量较正常减少超过2/3。两组间无显著差别,具有可比性。
1.2 治疗方法
治疗组于每周期化疗后出现食欲减退时予以健脾丸加味治疗,每日1剂,水煎服,每日2次,每次约200 ml,连服1周为1个疗程,其方具体为:人参8 g(另煎)、白术(麸炒)10 g、麦芽10 g、枳壳10 g、甘草6 g、茯苓10 g、木香10 g、砂仁5 g、六神曲10 g、山楂15 g、薏苡仁20 g。对照组不服用相关药物。
1.3 疗效标准
参照陈振东等[2]的标准适当修改:食欲增加>70%为显效;食欲增加>30%且<70%为有效;食欲增加<30%为无效。连续观察2个周期,每次于服药结束第2日评价疗效。
1.4 统计学方法
采用SPSS 15.0软件进行统计。计数资料采用χ2检验。
2 结果
治疗组42例共观察84个周期,显效61次,占72.6%;有效14次,占16.7%;无效9次,占10.7%。总有效率(显效率+有效率)为89.3%。对照组40例共观察80个周期,显效15次,占18.8%;有效20次,占25.0%;无效45次,占56.2%。总有效率为43.8%。两组比较差异有统计学意义(P=0.005<0.01),见表2。未发现患者有用药后不良反应。
3 讨论
化疗是治疗恶性肿瘤的重要方法之一,近年来随着新的化疗药物的问世,很多癌症患者的生存率不断提高。但因为食欲减退而影响身体和心理恢复 ......
您现在查看是摘要介绍页,详见PDF附件(1425KB,2页)。